Christos Nicholoudis - 08 Feb 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Christos Nicholoudis
Issuer symbol
TELO
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
3
Filing time
08 Feb 2024, 17:40:49 UTC
Previous filing
21 Aug 2023

No securities are beneficially owned.